Table 3.
Monitoring of regional citrate anticoagulation for continuous RRT
Parameter | Monitoring Intervals | Aim |
---|---|---|
Circuit ionized calcium (postfilter) | Within 1 h from the start of the treatment and then at least every 6–8 h | To evaluate the maintenance of circuit ionized calcium within the intended target and modify citrate dose accordingly |
Systemic ionized calcium | Baseline (before starting RRT) | To check baseline levels and set initial calcium infusion rate |
Within 1 h from the start of the treatment and then at least every 4–6 h | To evaluate the maintenance of systemic ionized calcium within the physiologic range and modulate calcium infusion rate accordingly | |
Systemic total calcium | At least every 12–24 h (simultaneous to systemic ionized calcium) | To calculate calcium ratio (total-to-ionized systemic calcium) as an indirect index of citrate accumulation (≥2.5) |
Acid-base parameters (pH and bicarbonate)a | Baseline (before starting RRT) | To exclude acid-base imbalances (metabolic acidosis or alkalosis) and modify RCA and RRT parameters setting if needed |
Within 1 h from the start of the treatment and then at least every 4–6 h | ||
Magnesium | At least every 24 h | To modulate the amount of magnesium supplementation if needed |
Serum sodium | Once daily | To exclude hypernatremia or hyponatremia (rarely observed with a correct matching of RCA solutions) |
Citratemia (if available) | Not routinely used for clinical purposes | To confirm hypercitratemia in the presence of indirect signs of citrate accumulation |
Serum lactate | Baseline (before starting RRT) | To identify patients at higher risk for citrate accumulation and monitor lactate levels during RCA |
At least every 6–12 h or according to clinical needs |
Sample drawn from an arterial line.